tesamorelin vs retatrutide comparison CagriSema 2026: Approval & Data Retatrutide and Tesamorelin the Combined
Description
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)
Quick note on supply and barriers to entry: The more complex scaling of supply, the more resources it requires to build out manufacturing capabilities, the harder it will be for new entrants to compete, even with better drugs or improved form factors (e.g., Amgens 1x/month treatment) if they cant keep up with supply
At moderate doses (4-8mg), the triple-receptor synergy kicks in fully
Diabetologia 52, 199207 (2009)
Kirkegrd, J., Mortensen, F
